臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 52363857 在线人数 : 921 教育部委托研究计画计画执行:国立台湾大学图书馆

搜寻范围

进阶搜寻

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"lih ching hsu"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 36-45 / 68 (共7页)
<< < 1 2 3 4 5 6 7 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-07-06T07:01:19Z	Hemiasterlin derivative (R)(S)(S)-BF65 and Akt inhibitor MK-2206 synergistically inhibit SKOV3 ovarian cancer cell growth	Lai W.-T.;Cheng K.-L.;Baruchello R.;Rondanin R.;Marchetti P.;Simoni D.;Lee R.M.;Guh J.-H.;Lih-Ching Hsu; Lai W.-T.; Cheng K.-L.; Baruchello R.; Rondanin R.; Marchetti P.; Simoni D.; Lee R.M.; Guh J.-H.; LIH-CHING HSU
臺大學術典藏	2021-07-06T07:01:19Z	Downregulation of COMMD1 by MIR-205 promotes a positive feedback loop for amplifying inflammatory- and stemness-associated properties of cancer cells	Yeh D.-W.;Chen Y.-S.;Lai C.-Y.;Liu Y.-L.;Lu C.-H.;Lo J.-F.;Chen L.;Lih-Ching Hsu;Luo Y.;Xiang R.;Chuang T.-H.; Yeh D.-W.; Chen Y.-S.; Lai C.-Y.; Liu Y.-L.; Lu C.-H.; Lo J.-F.; Chen L.; LIH-CHING HSU; Luo Y.; Xiang R.; Chuang T.-H.
臺大學術典藏	2021-07-06T07:01:19Z	Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: The role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways	Leu W.-J.;Swain S.P.;Chan S.-H.;Hsu J.-L.;Liu S.-P.;Chan M.-L.;Yu C.-C.;Lih-Ching Hsu;Chou Y.-L.;Chang W.-L.;Hou D.-R.;Guh J.-H.; Leu W.-J.; Swain S.P.; Chan S.-H.; Hsu J.-L.; Liu S.-P.; Chan M.-L.; Yu C.-C.; LIH-CHING HSU; Chou Y.-L.; Chang W.-L.; Hou D.-R.; Guh J.-H.
臺大學術典藏	2021-07-06T07:01:18Z	Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways	Chan M.-L.; Yu C.-C.; Hsu J.-L.; Leu W.-J.; Chan S.-H.; LIH-CHING HSU; Liu S.-P.; Ivantcova P.M.; Dogan ?.; Br?se S.; Kudryavtsev K.V.; Guh J.-H.
臺大學術典藏	2021-07-06T07:01:18Z	A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach	Marchetti P.;Pavan B.;Simoni D.;Baruchello R.;Rondanin R.;Mischiati C.;Feriotto G.;Ferraro L.;Lih-Ching Hsu;Lee R.M.;Dalpiaz A.; Marchetti P.; Pavan B.; Simoni D.; Baruchello R.; Rondanin R.; Mischiati C.; Feriotto G.; Ferraro L.; LIH-CHING HSU; Lee R.M.; Dalpiaz A.
臺大學術典藏	2021-07-06T07:01:17Z	Traversal of the Blood-Brain Barrier by Cleavable l -Lysine Conjugates of Apigenin	Wong T.-Y.; Tsai M.-S.; LIH-CHING HSU; Lin S.-W.; Liang P.-H.
臺大學術典藏	2021-07-06T07:01:17Z	Using precursor ion scan of 184 with liquid chromatography-electrospray ionization-tandem mass spectrometry for concentration normalization in cellular lipidomic studies	Chao H.-C.; Chen G.-Y.; LIH-CHING HSU; Liao H.-W.; Yang S.-Y.; Wang S.-Y.; Li Y.-L.; Tang S.-C.; Tseng Y.J.; Kuo C.-H.
臺大學術典藏	2021-07-06T07:01:16Z	The combination of MK-2206 and WZB117 exerts a synergistic cytotoxic effect against breast cancer cells	Li Y.-L.;Weng H.-C.;Hsu J.-L.;Lin S.-W.;Guh J.-H.;Lih-Ching Hsu; Li Y.-L.; Weng H.-C.; Hsu J.-L.; Lin S.-W.; Guh J.-H.; LIH-CHING HSU
臺大學術典藏	2021-07-06T07:01:16Z	Phosphodiesterase type 5 (PDE5) inhibitors sensitize topoisomerase II inhibitors in killing prostate cancer through PDE5-independent impairment of HR and NHEJ DNA repair systems	Chang J.-F.;Hsu J.-L.;Sheng Y.-H.;Leu W.-J.;Yu C.-C.;Chan S.-H.;Chan M.-L.;Lih-Ching Hsu;Liu S.-P.;Guh J.-H.; Chang J.-F.; Hsu J.-L.; Sheng Y.-H.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Chan M.-L.; LIH-CHING HSU; Liu S.-P.; Guh J.-H.
臺大學術典藏	2021-07-06T07:01:16Z	Para-toluenesulfonamide induces anti-tumor activity through Akt-dependent and -independent mTOR/p70S6K pathway: Roles of lipid raft and cholesterol contents	Hsu J.-L.; Leu W.-J.; LIH-CHING HSU; Liu S.-P.; Zhong N.-S.; Guh J.-H.

显示项目 36-45 / 68 (共7页)
<< < 1 2 3 4 5 6 7 > >>
每页显示[10|25|50]项目